Comparison of Biolimus A9–Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery Lesions | Zendy

JongYoung Lee | Zendy; DukWoo Park | Zendy; YoungHak Kim | Zendy; JungMin Ahn | Zendy; WonJang Kim | Zendy; SooJin Kang | Zendy; SeungWhan Lee | Zendy; Cheol Whan Lee | Zendy; SeongWook Park | Zendy; SungCheol Yun | Zendy; TaeHyun Yang | Zendy; BongKi Lee | Zendy; NaeHee Lee | Zendy; JooYoung Yang | Zendy; WonYong Shin | Zendy; Hun Sik Park | Zendy; KeeSik Kim | Zendy; SeungHo Hur | Zendy; Sung Yun Lee | Zendy; JongSeon Park | Zendy; Yun Seok Choi | Zendy; Seung Uk Lee | Zendy; SungHo Her | Zendy; SeungJung Park | Zendy

Open Access

Comparison of Biolimus A9–Eluting (Nobori) and Everolimus-Eluting (Promus Element) Stents in Patients With De Novo Native Long Coronary Artery Lesions

Author(s) -

JongYoung Lee,

DukWoo Park,

YoungHak Kim,

JungMin Ahn,

WonJang Kim,

SooJin Kang,

SeungWhan Lee,

Cheol Whan Lee,

SeongWook Park,

SungCheol Yun,

TaeHyun Yang,

BongKi Lee,

NaeHee Lee,

JooYoung Yang,

WonYong Shin,

Hun Sik Park,

KeeSik Kim,

SeungHo Hur,

Sung Yun Lee,

JongSeon Park,

Yun Seok Choi,

Seung Uk Lee,

SungHo Her,

SeungJung Park

Publication year - 2014

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.113.000841

Subject(s) - medicine , restenosis , percutaneous coronary intervention , drug eluting stent , stent , target lesion , everolimus , cardiology , coronary artery disease , myocardial infarction , confidence interval

Procedural and clinical outcomes still remain unfavorable for patients with long coronary lesions who undergo percutaneous coronary intervention. The current study, therefore, evaluated 2 innovative drug-eluting stents for the management of long-lesion coronary artery disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research